Botulinum Toxin Type A Reconstituited with Lidocaine: A Report of 356 Consecutive Cases

Abstract

Background: The purpose of this paper is to evaluate the predictability of the off-label aesthetic use of botulinum toxin type A (BoNTA) reconstituted with lidocaine. Material and Methods: Three-hundred and fifty-six (356) BoNTA treatments were performed on 118 patients, between the January 2010 and the January 2013; BoNTA was reconstituited with lidocaine. Results: A few minute after the BoNTA injection the effect of muscle paralysis was seen in all the cases, this allowed the Author to provide an optimal symmetric result with no need of a touch up procedure at the control after a week. Maior complication were not registered. Conclusion: The results of this study shows how the reconstitution of BoNTA with lidocaine may avoid imperfect results after the injections; all components retain their function and immediate feedback on the extent of paralysis to be expected from the chemodenervation action of BoNTA let the physician to have an immediate control of the final result. Keywords: Botulinum toxin, Facial aesthetic, Minimally-invasive, Lidocaine.